Stock MoversStock Movers

Eli Lilly Gains on Experimental Shot, Gemini Space Station Rises, Oracle Sinks on 3Q Forecast

View descriptionShare
 

On this episode of Stock Movers:

- Eli Lilly (LLY) gains 2.6% as a late-stage study showed that a next-generation obesity shot helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet.

- Gemini Space Station (GEMI) rose 20% after its application for a derivatives exchange was approved by the Commodity Futures Trading Commission in a move that will allow the company to join the fast-growing field of prediction markets.

- Oracle (ORCL) sank 13% after the company forecast 3Q cloud sales growth below analyst estimates, raising concerns that supply constraints are preventing the cloud infrastructure provider from converting its large backlog to actual revenues.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Su 
Social links
Follow podcast
Recent clips
Browse 2,095 clip(s)